Mutagenicity and safety pharmacology of a standardized antidiabetic polyherbal formulation

Synacinn is a standardized polyherbal extract formulated for the treatment of diabetes mellitus and its complications. This study aims to assess the mutagenicity potential of Synacinn by Ames assay and in vivo bone marrow micronucleus (MN) test on Sprague Dawley rat. Human ether-a-go-go-related gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdul Majid, Fadzilah Adibah, Fadhlina, Anis, Ismail, Hassan Fahmi, Zainol, Siti Nurazwa, Mamillapalli, Archan Kumar, Venkatesan, Vijayabalaji, Eswarappa, Rajesh, Pillai, Renuka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065066/
https://www.ncbi.nlm.nih.gov/pubmed/35505003
http://dx.doi.org/10.1038/s41598-022-11243-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065066/
https://www.ncbi.nlm.nih.gov/pubmed/35505003
http://dx.doi.org/10.1038/s41598-022-11243-3

Ejemplares similares